FDA to follow EMA with move from London to Amsterdam
As the FDA now communicates with its European counterparts on a daily basis, the US agency has decided to make the move from London to Amsterdam alongside the EMA.
“By maintaining an office in both Brussels and London (eventually Amsterdam), we can better leverage our resources and collaborate with our regulatory partners on higher-risk sites around the globe that sell food and medical products to both Europe and the United States,” the FDA’s Anna Abram and Mark Abdoo wrote in a blog post Thursday.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
